Member Info for PanamaPete

Should the vote be 'FOR' delisting, SDX will offer a Matched Bargain Facility for Ordinary Shares.

There is the opportunity to vote again or amend a previous instruction. I have accumulated a small holding < 1,000,000 & will be voting NO for delisting. GLA

The potential delisting does not negate the value of your holding. Some brokers may be able to deal through the JP Jenkins share dealing platform. Interesting times.

https://jpjenkins.com/list-of-brokers/

"The targeted sale of our Egypt, Italy and Croatia portfolio (the "Transaction") to an entity controlled by Carlyle International Energy Partners ("Carlyle") is on track for completion by or just after year-end 2024, supporting our focus on core assets, deleveraging, and delivering incremental shareholder returns."

Hoping this would have concluded by year end but not long to wait now.

The 2030 EV deadline was unachievable. First sensible decision this Labour government has made. Driving oversized milk carts with 5yr battery life is not the the answer. Now if they can just drop the £20bn carbon capture commitment & reverse the employers NIC increase, things might start to improve.

A lot of boxes being ticked. Ducks lining up 222. Must be some predators looking at GDR now.

I would be very surprised if we didn't get a Directors purchase or TR-1 holdings RNS before year end. Sales will come, revenue will come & the runway will be extended significantly imho. DYOR, usual caveats. GLA

Important word “actively”.

UK Stroke Forum Conference

“We are excited to be exhibiting at the UK Stroke Forum Conference at the ACC in Liverpool from the 3rd to 5th December 2024. Join us to discover the latest research and service developments with sessions focused on different aspects of stroke care – including informative training streams, groundbreaking keynote lectures, exciting debate and panel discussions and Soapbox session.

3 5 Dec 2024, ACC, Liverpool, UK”

“The Company also continues to actively seek non-dilutive funding and participation in the DEVOTE programme saw the Company receive c£0.2m and avoid a further c.£1.0m of costs that would otherwise have been absorbed by the Company for the successful validation and verification of our CYP2C19 product.”

Stock, no I can't advise on the sales from 2025 but they are unlikely to be zero.

Stock, you have forgotten to include sales from 2025.

Now the results are out of the way, Directors are free to buy. Let's see how confident they are.

The time to buy was at 850p when there were fears of missile attacks. I sold at 1017p a while back & will be tempted back in under 950p. The ongoing dividend policy needs clarification. Production guidance has been lowered. The special dividend is cash out of the coffers which has to be accounted for.

Coming up on LBC this morning, an article about the increase in strokes in middle aged people.

The results be be released via RNS on Friday 29th Nov, the presentation the following Monday 2nd Dec.

Roger, I did read the RNS & especially Gino's comments at the end:

"The programme will run in parallel with, and be complementary to, our continued sales expansion, nationally and internationally."

I also don’t think another fund raise is viable. Gino may be looking for a buyer. imho dyor etc.

Maybe you’d like a hot-line to Gino. I’m sure he has nothing better to do than assuage your concerns.

And yet you talk of no communication from Gino for months. That RNS was only 15 days ago. Get a grip.